Procalmadiol

Procalmadiol Brand names, Procalmadiol Analogs

Procalmadiol Brand Names Mixture

No information avaliable

Procalmadiol Chemical_Formula

C₂₀H₂₃NS

Procalmadiol RX_link

No information avaliable

Procalmadiol fda sheet

Procalmadiol msds (material safety sheet)

Procalmadiol Synthesis Reference

No information avaliable

Procalmadiol Molecular Weight

309.469 g/mol

Procalmadiol Melting Point

< 25 ^oC

Procalmadiol H₂O Solubility

Soluble as HCl salt

Procalmadiol State

Liquid

Procalmadiol LogP

5.7

Procalmadiol Dosage Forms

Tablets (oral, 1 mg)

Procalmadiol Indication

Used for the symptomatic treatment of parkinsonism.

Procalmadiol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Procalmadiol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Procalmadiol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Procalmadiol Patient Information

Procalmadiol Organisms Affected

Humans and other mammals